Advertisement
Corrections

Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Changqing Xie, Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry-Hrones, Melissa Walker, Cecilia Monge Bonilla, Bradford J. Wood, Deborah E. Citrin, Elizabeth M. Gil Ramirez, Freddy E. Escorcia, Bernadette Redd, Jonathan M. Hernandez, Jeremy L. Davis, Billel Gasmi, David Kleiner, Seth M. Steinberg, Jennifer C. Jones and Tim F. Greten
DOI: 10.1158/1078-0432.CCR-20-4640 Published January 2021

In the original version of this article (1), the graph lines were mislabeled in Fig. 2C and D. The graphs have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Footnotes

  • Clin Cancer Res 2021;27:358

Reference

  1. 1.↵
    1. Xie C,
    2. Duffy AG,
    3. Brar G,
    4. Fioravanti S,
    5. Mabry-Hrones D,
    6. Walker M,
    7. et al.
    Immune checkpoint blockade in combination with stereotactic body radiotherapy in patients with metastatic pancreatic ductal adenocarcinoma. Clin Cancer Res 2020;26:2318–26.
    OpenUrlAbstract/FREE Full Text
Back to top
View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Changqing Xie, Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry-Hrones, Melissa Walker, Cecilia Monge Bonilla, Bradford J. Wood, Deborah E. Citrin, Elizabeth M. Gil Ramirez, Freddy E. Escorcia, Bernadette Redd, Jonathan M. Hernandez, Jeremy L. Davis, Billel Gasmi, David Kleiner, Seth M. Steinberg, Jennifer C. Jones and Tim F. Greten
Clin Cancer Res January 1 2021 (27) (1) 358; DOI: 10.1158/1078-0432.CCR-20-4640
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement